Independent Advisor Alliance’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.66M Sell
33,020
-1,415
-4% -$157K 0.11% 170
2025
Q1
$3.86M Buy
34,435
+2,307
+7% +$258K 0.13% 149
2024
Q4
$2.97M Buy
32,128
+8,398
+35% +$776K 0.04% 403
2024
Q3
$1.99M Buy
23,730
+270
+1% +$22.6K 0.07% 224
2024
Q2
$1.61M Buy
23,460
+6,594
+39% +$452K 0.06% 253
2024
Q1
$1.24M Buy
16,866
+1,513
+10% +$111K 0.04% 287
2023
Q4
$1.24M Buy
15,353
+975
+7% +$79K 0.04% 274
2023
Q3
$1.08M Buy
14,378
+7,794
+118% +$584K 0.05% 285
2023
Q2
$507K Buy
6,584
+756
+13% +$58.3K 0.02% 424
2023
Q1
$484K Buy
+5,828
New +$484K 0.02% 429
2022
Q4
Sell
-8,201
Closed -$506K 504
2022
Q3
$506K Buy
8,201
+868
+12% +$53.6K 0.03% 371
2022
Q2
$453K Sell
7,333
-426
-5% -$26.3K 0.03% 390
2022
Q1
$461K Buy
7,759
+357
+5% +$21.2K 0.02% 413
2021
Q4
$537K Buy
7,402
+230
+3% +$16.7K 0.03% 379
2021
Q3
$501K Sell
7,172
-436
-6% -$30.5K 0.03% 381
2021
Q2
$524K Buy
7,608
+659
+9% +$45.4K 0.03% 383
2021
Q1
$449K Sell
6,949
-309
-4% -$20K 0.03% 395
2020
Q4
$423K Sell
7,258
-1,030
-12% -$60K 0.03% 373
2020
Q3
$524K Sell
8,288
-32,560
-80% -$2.06M 0.04% 286
2020
Q2
$932K Buy
40,848
+23,756
+139% +$542K 0.1% 167
2020
Q1
$1.28M Buy
17,092
+8,822
+107% +$660K 0.19% 97
2019
Q4
$537K Sell
8,270
-631
-7% -$41K 0.02% 512
2019
Q3
$564K Buy
8,901
+475
+6% +$30.1K 0.07% 238
2019
Q2
$569K Buy
8,426
+219
+3% +$14.8K 0.08% 209
2019
Q1
$534K Sell
8,207
-632
-7% -$41.1K 0.08% 223
2018
Q4
$553K Buy
8,839
+851
+11% +$53.2K 0.1% 182
2018
Q3
$526K Buy
7,988
+765
+11% +$50.4K 0.09% 177
2018
Q2
$440K Sell
7,223
-350
-5% -$21.3K 0.09% 194
2018
Q1
$555K Sell
7,573
-123
-2% -$9.01K 0.12% 178
2017
Q4
$573K Buy
7,696
+162
+2% +$12.1K 0.13% 167
2017
Q3
$618K Buy
7,534
+337
+5% +$27.6K 0.17% 139
2017
Q2
$499K Sell
7,197
-3,679
-34% -$255K 0.16% 147
2017
Q1
$723K Sell
10,876
-12,150
-53% -$808K 0.11% 197
2016
Q4
$1.64M Buy
+23,026
New +$1.64M 0.7% 42